InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,978.68
(
0.13%
)
Post# of 304039
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ADVFN_bioking

Send PM Follow Ignore
Followers 0
Posts 596
Boards Moderated 0
Alias Born 05/15/2017

ADVFN_bioking

Re: None

Thursday, 12/05/2019 10:25:07 AM

Thursday, December 05, 2019 10:25:07 AM

Post# of 304039
VRNA =MC $57 M / Cash $51 M / COPD phase 2b results within days /low float stock =Quick 200% Upside Gem ......
http://wsw.com/webcast/jeff123/vrna/3__SlideJDJGMK17.jpg?rand=55695

"We are very pleased that our four-week Phase 2b dose-ranging clinical trial with nebulized ensifentrine is progressing according to plan and that we have completed enrollment of over 400 symptomatic patients with moderate to severe COPD. Enrollment completed on schedule with data expected around year end 2019"
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up